In this study, we found that BRCA1/2 variant carriers treated with BCT have a survival rate comparable to that of those treated with mastectomy with radiotherapy or mastectomy alone after adjusting for clinicopathologic factors and adjuvant therapy in this large, consecutive series of unselected patients with breast cancer. Here, BRCA1 is linked to breast carcinoma.